EASTON PHARMACEUTICALS INC (OTCMKTS:EAPH) Sellers Reduced By 77.11% Their Shorts As Of Jan 14, 2019

Easton Pharmaceuticals Inc. (OTCMKTS:EAPH) Corporate Logo

It was showed a decrease on EASTON PHARMACEUTICALS INC (OTCMKTS:EAPH)’s short interest with 77.11%. It was announced in January by FINRA the 19,000 short interest on EAPH. That’s 77.11% down from 83,000 shares.

EAPH reached $0.0077 during the last trading session after $0.0005 change.Easton Pharmaceuticals Inc. has 3.38 million shares volume, 22.01% up from normal. EAPH is and has moved 0.00% since January 14, 2018. The stock the S&P 500 by 0.00%.

Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products.The firm is worth $9.33 million. The Company’s products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug.Last it reported negative earnings. The firm is also developing XILIVE, an early stage cancer drug.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.